BTTX
Better Therapeutics (BTTX)
$00
About Better Therapeutics (BTTX)
Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions. The company was founded by Kevin J. Appelbaum and David P. Perry in April 2015 and is headquartered in San Francisco, CA.
Details
Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.47
52 Week Low
$0.00
Market cap
5,400
Dividend yield
0.00%
Volume
10,725
Avg. volume
14,453
P/E ratio
.00
Better Therapeutics News
Details
Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.47
52 Week Low
$0.00
Market cap
5,400
Dividend yield
0.00%
Volume
10,725
Avg. volume
14,453
P/E ratio
.00